Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    0.00 (0.00%)
Bid:
0.00
Ask:
1,440.00
Spread: 210.00 (17.073%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Aug 2012 11:29

RNS Number : 1678K
Oryx International Growth Fund Ld
16 August 2012
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

 Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -4.24% and the FTSE All-Share TR Index (£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

 The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

 Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

 24 April 2012 a total of 379,653 ordinary shares at a gross price of £2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

 Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

 

 

30 June 2012 

31 March 2012 

31 December 2011 

30 September 2011 

30 June 2011 

 

 

 

 

 

 

NAV

£2.93

£3.03

£2.79

£2.69

£2.96

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5685

 

1.5978

 

1.5541

 

1.5579

 

1.6055

 

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2012

 

% Net Assets

Cvs Group Plc

7.85

Bioquell Plc

6.84

Gleeson (M.J.) Group Plc

6.67

Guinness Peat Group Plc

6.36

Orthoproducts Ltd

4.99

Augean Plc

4.96

Journey Group Plc

4.29

Eckoh Plc

4.28

Quarto Group Inc

4.26

Catalyst Media Group Plc

4.14

Assetco Plc

3.80

Innovation Group Plc

3.76

Sinclair Is Pharma Plc

3.23

Rpc Group Plc

2.75

Nastor Inv Ltd Zero Redeem Prefer Shares

2.61

Mecom Group Plc

2.42

Bionostics Holdings Ltd

2.40

Celsis Ag

2.09

Bavaria Industriekapital Ag

2.09

Sinav Limited

1.99

81.78

 

 

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUCPRUPPGUQ
Date   Source Headline
25th Jul 20144:45 pmRNSNet Asset Value(s)
22nd Jul 20144:57 pmRNSHolding(s) in Company
22nd Jul 20144:55 pmRNSHolding(s) in Company
18th Jul 20143:57 pmRNSCirc re. AGM and waiver
7th Jul 20143:56 pmRNSUpdate of Investment Restrictions
2nd Jul 20147:00 amRNSAnnual Financial Report
24th Jun 20145:32 pmRNSNet Asset Value(s)
29th May 20144:19 pmRNSNet Asset Value(s)
22nd May 20144:12 pmRNSHolding(s) in Company
28th Apr 201412:35 pmRNSHolding(s) in Company
25th Apr 20141:07 pmRNSNet Asset Value(s)
2nd Apr 201411:16 amRNSHolding(s) in Company
27th Mar 20146:00 pmRNSNet Asset Value(s)
10th Mar 20142:20 pmRNSHolding(s) in Company
27th Feb 20141:30 pmRNSNet Asset Value(s)
14th Feb 20143:00 pmRNSInterim Management Statement
13th Feb 20142:57 pmRNSHolding(s) in Company
30th Jan 20144:00 pmRNSNet Asset Value(s)
22nd Jan 20143:36 pmRNSHolding(s) in Company
22nd Jan 20143:31 pmRNSHolding(s) in Company
21st Jan 20144:16 pmRNSHolding(s) in Company
20th Jan 20145:32 pmRNSTransaction in Own Shares
20th Jan 20145:20 pmRNSHolding(s) in Company
13th Jan 20141:50 pmRNSHolding(s) in Company
27th Dec 20135:00 pmRNSTransaction in Own Shares
19th Dec 20135:00 pmRNSNet Asset Value(s)
11th Dec 20135:55 pmRNSHolding(s) in Company
3rd Dec 201310:15 amRNSHolding(s) in Company
3rd Dec 20139:45 amRNSHolding(s) in Company
2nd Dec 20132:57 pmRNSHolding(s) in Company - Replacement
29th Nov 20131:30 pmRNSTransaction in Own Shares
26th Nov 20133:27 pmRNSHolding(s) in Company
25th Nov 20135:03 pmRNSTransaction in Own Shares
25th Nov 20135:00 pmRNSHolding(s) in Company
25th Nov 20133:03 pmRNSHalf Yearly Report
22nd Nov 20133:45 pmRNSNet Asset Value(s)
18th Nov 20139:47 amRNSHolding(s) in Company
15th Nov 20134:00 pmRNSHoldings in Company
5th Nov 20131:00 pmRNSHolding(s) in Company
23rd Oct 20134:15 pmRNSHolding(s) in Company
21st Oct 20134:59 pmRNSNet Asset Value(s)
18th Oct 20133:00 pmRNSHolding(s) in Company
14th Oct 201311:16 amRNSHolding(s) in Company
7th Oct 20138:15 amRNSHolding(s) in Company
3rd Oct 20135:07 pmRNSTransactions in a Close Period
1st Oct 20132:48 pmRNSTransaction in Own Shares
30th Sep 20133:29 pmRNSTransaction in Own Shares
20th Sep 20134:30 pmRNSNet Asset Value(s)
19th Sep 20134:35 pmRNSTransaction in Own Shares
12th Sep 20137:00 amRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.